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Abstract
Background—Increasing numbers of individuals are choosing to opt out of population-based
sampling frames due to privacy concerns. This is especially a problem in the selection of controls
for case–control studies, as the cases often arise from relatively complete population-based
registries, whereas control selection requires a sampling frame. If opt out is also related to risk
factors, bias can arise.
Methods—We linked breast cancer cases who reported having a valid driver’s license from the
2004–2008 Wisconsin women’s health study (N = 2,988) with a master list of licensed drivers
from the Wisconsin Department of Transportation (WDOT). This master list excludes Wisconsin
drivers that requested their information not be sold by the state. Multivariate-adjusted selection
probability ratios (SPR) were calculated to estimate potential bias when using this driver’s license
sampling frame to select controls.
Results—A total of 962 cases (32%) had opted out of the WDOT sampling frame. Cases age <40
(SPR = 0.90), income either unreported (SPR = 0.89) or greater than $50,000 (SPR = 0.94), lower
parity (SPR = 0.96 per one-child decrease), and hormone use (SPR = 0.93) were significantly less
likely to be covered by the WDOT sampling frame (α = 0.05 level).
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Conclusions—Our results indicate the potential for selection bias due to differential opt out
between various demographic and behavioral subgroups of controls. As selection bias may differ
by exposure and study base, the assessment of potential bias needs to be ongoing.
Impact—SPRs can be used to predict the direction of bias when cases and controls stem from
different sampling frames in population-based case–control studies.
Introduction
Selection bias in population-based cancer research can affect the validity of the evidence
used for public health practice (1). In epidemiologic case–control studies, cases and controls
should arise from the same study base (2–5). However, the nature of case–control studies
may lead to different sampling frames being used for cases and controls. For example, cases
may arise from physician reports in a geographic region, whereas controls are selected from
some type of list of the population in the same region. This is the situation when a statewide
cancer registry is used to sample cases and a state-provided master file of licensed drivers is
used to sample controls. Such studies make the assumption that coverage of the study base is
comparable for both the case and control sampling frames. If the study base is all residents
in a geographical area, then the case sampling frame needs to include all incident cases in
that area, and the control sampling frame needs to include all residents in the same area.
Bias will arise if sampling frame coverage of the study base is associated differently with
risk factors among cases and controls. Inherently, there is no association of coverage with
risk factors among cases, when a registry is nearly complete. If, however, no complete
sampling frame exists for controls, bias will then arise if coverage of the control sampling
frame is associated with risk factors. The potential for bias varies by exposure, sampling
frame, and geographical setting requiring a fresh evaluation for most studies. While
response rates and nonresponse error have been discussed extensively in the epidemiologic
literature (6–10), the effects of the completeness of sampling frames have received little
attention.
An official master file of drivers with valid licenses is available for epidemiologic studies in
many states (11). Although coverage may vary, such files have historically been sufficiently
complete to constitute a useful sampling frame (12–13). The largest coverage problems have
resulted from (i) individuals who are not old enough to drive, (ii) those who have stopped
renewing, or (iii) those who never obtained a driver’s license. More recently, legal
constraints have compromised the coverage of these files. To comply with the Driver’s
Privacy Protection Act (DPPA: 18 U.S.C. 2721–2725), the state of Wisconsin has instituted
an "opt-out" program allowing drivers the option of keeping driver’s license data
confidential and unavailable to research organizations. Using data from a population-based
breast cancer case–control study and the Wisconsin Department of Transportation
(WDOT),we had an opportunity to examine the effects of "opt out" due to privacy concerns
affecting the sampling frame used to select population-based controls on the validity of
study results.
Materials and Methods
Wisconsin women’s health study
This analysis used data from the breast cancer cases enrolled in the Wisconsin women’s
health study (WWHS), a federally funded population-based case–control study designed to
examine the associations of lifestyle factors and genetics with breast cancer risk (14).
WWHS cases were incident breast cancer cases reported to the mandatory statewide cancer
registry and interviewed for our study between 2004 and 2008. Data from the statewide
cancer registry met high completeness standards (90%–95% complete). Some issues with
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completeness due to failure of neighboring states in reporting cases have been previously
addressed (15). Cases (N = 2,988; 74% response rate) completed a 35-minute structured
telephonic interview. In addition to detailed questions concerning medication use, cases
were queried about demographic characteristics, reproductive history, personal and family
cancer history, physical activity, smoking, and alcohol consumption. Controls in the parent
study were identified using a master file compiled by the WDOT of all licensed drivers,
excluding the individuals who "opted out." This investigation used only data from the
WWHS cases to investigate selection bias due to incomplete control sampling frame
coverage.
Linkage
We matched the participating 2,988 WWHS breast cancer cases to WDOT driver’s license
files of individuals who had not "opted out" to estimate the completeness of the driver’s
license sampling frame used to select controls. WWHS cases were linked with data from the
2006 WDOT master file. A dichotomous variable was created indicating whether each
WWHS case record matched a record from the driver’s license master file. First, exact
match linkages were conducted on the basis of gender, last name, first name, date of birth,
and zip code between WWHS case records and WDOT driver’s license records. Second,
manual review of exact match linkages was conducted based first on gender, last name, first
name, and date of birth and then based on gender, last name, and date of birth for all
remaining unmatched case records. Manual review of the remaining unmatched WWHS
cases, aided by various weighting schemes developed by the National Center for Health
Statistics for the National Death Index, was then used to find any additional cases with
matching WDOT license records (16).
Selection probability ratio calculation
It has been shown that the ratio of the probability of being on the sampling frame among
individuals with a risk factor divided by the corresponding probability among those without
the risk factor is a measure of the bias in the estimated odds ratio (OR) of disease for the
factor (17–19). We will use such ratios to estimate the magnitude of bias that may be
expected. For a given risk factor under investigation in a case–control study, let α denote the
probability of a case with the risk factor being on the sampling frame used for cases, and let
β denote the probability of a case without the risk factor being on the sampling frame used
for cases. Let γ and δ denote the corresponding probabilities among controls of being on the
sampling frame used to select controls, and OR, the true crude OR between the risk factor
and disease. Previous work on bias focused on the effects of participation bias, but applies to
the situation when lack of participation is caused by absence from the sampling frame used
to select either cases or controls. This work has shown that the estimated OR under the
scenario described is [(α/β)/(γ/δ)] × OR; thus [(α/β)/(γ/δ)] is a measure of bias. It was also
shown that the same principle can be applied to an adjusted OR, using adjusted estimates of
(α/β) and (γ/δ) obtained by averaging corresponding stratum specific quantities with the
weights used in averaging the stratum-specific log ORs (19–20). It should be noted that if
(α/β) = (γ/δ), that is, risk factors affect coverage the same way among cases and controls,
there is no bias. However, in our situation using data from the WWHS, case reporting to the
Wisconsin Cancer Reports System is nearly 100% complete, so α/β = 1. This implies there
will be bias if γ/δ ≠ 1, that is, if risk factors are associated with control sampling frame
coverage.
As risk factor information is not available for controls who are not on the drivers’ license
data frame, it is not possible to directly estimate γ/δ for the controls. Under the assumption
that opting out patterns are similar for cases and controls, however, γ/δ is the ratio
associated with opt out among both cases and controls, and we can estimate γ/δ from our
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match of cases to the drivers’ license file. The selection probability ratio (SPR) 1/(γ/δ) can
then be used to estimate the magnitude of bias. It should be noted that this is using data on a
subset of cases solely for the estimation of bias in the control group, whereas all cases will
be included in the final case–control analysis. Figure 1 illustrates how various SPR values
might affect a study’s results.
Statistical analysis
Analyses were conducted with SAS version 9.1 (SAS Institute). Among the 2,988 WWHS
cases, we modeled probabilities of cases being on the sampling frame provided in 2006 by
the WDOT on the basis of demographics (e.g., age, education, and income), lifestyle
characteristics (e.g., physical activity, obesity, and alcohol intake), and medical factors (e.g.,
cancer screening and comorbidities). Multivariable-adjusted SPRs were estimated by fitting
a generalized linear model with the log link function, poisson distribution, and robust error
variance to the WWHS cases (17). Demographic factors (race, income, education, age, and
marital status) and breast cancer risk factors (age at first birth, parity, antidepressant
medication use, hormone replacement therapy, oral contraceptive use, body mass index at
time of diagnosis, smoking status, total alcohol consumption, menopause status, family
history of cancer, and age at menarche) were included in the initial models. While the
demographic factors listed earlier were retained in all models, other breast cancer risk
factors with P values greater than 0.20 were removed sequentially to obtain the final
sampling frame coverage model.
The approach here to obtain ORs for specific risk factors and sampling ratios for coverage
probabilities from separate regression analyses does not fulfill the criterion of the same
weighting across adjustment variables or strata. Hence, the sampling ratios cannot be used to
directly correct the ORs (18). Nonetheless, the adjusted SPRs provide guidance as to the
expected magnitude of bias, and will be similar to those desired for correction if interaction
effects are insignificant in the disease model, thereby minimizing the influence of the choice
of averaging weights.
Results
The WDOT master file of licensed drivers for November 2006 included 3,018,192 records.
This master file was linked with the 2,988 breast cancer cases that participated in the
WWHS. A total of 2,026 (67.8%) of the WWHS cases were found to have a matching
record on the WDOT master file. Of these 2,026 cases, 1,477 (72.9%) had an exact match
based on gender, last name, first name, date of birth, and zip code. An additional 391 cases
(19.3%) were matched on the basis of gender, last name, first name, and date of birth, and
66 (3.3%) were matched on gender, last name, and date of birth. Manual review, aided by
weighting schemes based on those used by the National Death Index, matched 92 (4.5%)
additional cases.
Table 1 shows the characteristics of breast cancer cases by presence versus absence on the
sampling frame. Reference groups were chosen to represent commonly accepted groups
with decreased risk of breast cancer. Case SPRs ranged from 0.71 to 1.12. Breast cancer
cases found on the WDOT sampling frame were more likely to be older than 40 (SPR, 1.12)
than breast cancer cases under the age of 40. A greater percentage of cases who were
married, widowed, or single and never married were found on the WDOT master file than in
cases who were divorced, separated, or living with a partner. Compared with cases with
parity of 3 or more, all other cases were less likely to be found on the WDOT master file.
Each one-child decrease in parity significantly predicted coverage on the WDOT sampling
frame with a SPR of 0.96 [95% confidence interval (CI), 0.94–0.98; data not shown].
Compared with 71% of cases reporting earnings of less than $50,000, 66% of cases
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reporting incomes over $50,000 and 64% of cases who did not report income were linked
with a record from the WDOT sampling frame (data not shown). In addition, cases reporting
the use of hormone replacement therapy were less likely to be covered by the WDOT
sampling frame. Oral contraceptive use, body mass index at time of diagnosis, smoking
status, alcohol consumption, menopause status, age of menarche, and family history of
cancer were not associated with coverage on the WDOT sampling frame (data not shown).
Discussion
Awareness of selection bias in specific studies and study design types is important for both
researchers and policy makers in public health. In case–control studies, selection bias may
be compounded as cases and controls are often taken from different sampling frames but
assumed to represent the same study base. Hence, selection is associated with disease
outcome, and if this selection is also associated with specific risk factors, bias may result.
This study used breast cancer cases from an interview-based case–control study to examine
coverage error of the WDOT sampling frame used to select controls from the population.
This approach assumes that factors associated with coverage are similar in both case and
control groups. In this database, 31% of cases (N = 926) found in the WDOT master file
renewed their driver’s license after being diagnosed with cancer. For those cases, we were
unable to determine their opt-out status before diagnosis. However, removing those 31% of
cases did not change the factors determined to be associated with "opt out". In addition, to
argue that the determinants of opting out of the WDOT sampling frame are the same in this
population of cases as in the general population, one would have to assume that
nonparticipants have the same determinants of opting out as the cases that took part in this
study, and that these determinants have the same magnitude of association with opting out.
While this may be a valid assumption, more research is needed on the cases that did not
participate in the WWHS study to evaluate whether the opt-out determinants remain
consistent.
This research indicates that breast cancer cases under 40 years of age are more likely to "opt
out". Bias due to this finding in breast cancer research would be expected to be minimal
with approximately 6% of all incident breast cancer cases occurring in women under the age
of 40 (21). However, the finding may forecast a future deterioration of the coverage of this
sampling frame if one assumes that the majority of respondents that have opted out will
likely not opt back into the list sold by the state. Another option available to researchers
would be to simply exclude those cases where bias is most likely. In this case that would be
women under the age of 40. The potential for misinterpretation of results may be more
serious than the loss of precision due to the smaller sample size. However, potentially
informative data on these subgroups would be lost. Researchers could also use interaction
effects to evaluate stratum specific estimates of bias related to opt out in these subgroups.
Of interest to breast cancer research were the findings that parity, income, and the use of
hormone replacement therapy were associated with coverage on the sampling frame used to
select controls. Women with higher parity, lower income, and never users of
postmenopausal hormones are also less likely to develop breast cancer. Using a sampling
frame that has fewer women with high parity, fewer women with high incomes, and fewer
women who have ever used hormones to select controls may bias the results of a case–
control study when those risk factors are included as primary exposures or as covariates. By
assuming the same SPRs for cases and controls, we estimate control SPRs < 1.0 for greater
parity, higher income, and use of hormone replacement therapy. Control SPRs < 1.0 would
create observed ORs that are numerically higher than the truth (positive bias) when
evaluating these factors in case–control studies that use driver’s license master files to
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identify controls. For example, although there is widespread agreement that postmenopausal
estrogen–progesterone therapy is a risk factor for the development of breast cancer, an OR
from a case–control study that uses the driver’s license master file to identify controls that
enabled potential controls to opt out due to privacy concerns would likely be overestimated.
For conditions other than breast cancer, these factors (income, postmenopausal hormone
use, and parity) are also likely associated with socioeconomic variables.
One simple option for reducing selection bias may be to exclude cases not on the sampling
frame used to select the controls. It is often assumed that this exclusion ensures that the
study bases for cases and controls are comparable. However, this option requires one of the
assumptions that we made in our investigation: that factors responsible for opting out are the
same between cases and controls. Selection bias will remain even after excluding cases that
could not be approached to serve as controls if this assumption is not met. In addition, the
exclusion of potentially up to 32% of cases would be wasteful in terms of statistical power
and precision. Besides using SPRs to approximate the selection bias due to inadequate
sampling frame coverage, a researcher could calculate the predicted probability of coverage
for each control and use inverse probability weighting or propensity scores to adjust for
selection bias (17, 20, 22, 23). This approach has been used in previous research to adjust
for variations in nonresponse between cases and control in population-based case–control
studies on cancer etiology (20). This would require the additional assumptions that the
coverage model was properly specified without omitting relevant factors or interaction
terms.
Investigators should evaluate the comparability of each sampling frame’s study base when
designing the study. When coverage of the study base differs between cases and controls,
investigators should calculate the expected direction of bias indicated by the SPR for each
exposure of interest and use one of the established correction methods to adjust results,
when a new exposure of interests is evaluated. A previous study (24) investigated the
association of study participation with molecular exposures and concluded that, although
there was no association, further research is needed. It should be noted that for selection to
create bias, association with a risk factor is a necessary, but not sufficient, condition for bias,
as the SPR can still be equal to 1. For SPRs not to equal 1, participation also needs to be
associated with disease outcome conditionally on the risk factor, which can occur due to
different sampling frames. Bias is less likely in a case–control study nested in a cohort study
as, barring selective drop out, disease outcome occurs postenrollment. A similar argument
that opt out is likely unrelated to case–control status, as it mostly occurred before cancer
diagnosis, is used in our estimation approach.
Also, this study assumed that the case sampling frame, the Wisconsin Cancer Reporting
System, was 100% complete. This allows for a simplified calculation of SPRs based on
setting α and β to 1. There appears to be regional variation in reporting due to privacy
concerns of neighboring states (15). Additional research could focus on the effects of this
variation.
This study and linkage procedures have some limitations. In addition to the assumptions
discussed earlier, some errors in linkage between WWHS cases and the WDOT master list
of licensed drivers may have occurred. Linkage procedures could partially explain the
observed association between marital status and coverage. The first 3 linkage procedures
used last name and address when merging the driver’s license list with WWHS case data.
Last name and/or address often change when marital status changes. However, these data are
normally updated when a license is renewed (every 7 years in Wisconsin). Also, linkages
focusing on date of birth, aided by various weighting schemes, were evaluated to reduce
misclassification. The WWHS parent study obtained a master list of licensed drivers in 2004
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and 2006. However, due to cost constraints only the 2006 master file was prepared for
linkage. Cases that were interviewed in 2004 may have moved away, passed away or had a
disease progression that would explain absence from the 2006 master list of licensed drivers.
However, the 2-year emigration and mortality rates are low for these women. Additional
linkage errors probably resulted in nondifferential misclassification bias, resulting in
attenuated SPRs.
Our results indicate the potential for selection bias due to differential opt out between
various demographic and behavioral subgroups of controls. The potential for bias due to
inadequate coverage of the study base will increase if more individuals opt out of inclusion
in common sampling frames used in cancer research. All current control ascertainment
schemes, including random digit dialing, have coverage issues, and as response rates and
participation rates decline, understanding the effects of sampling frames that do not fully
enumerate the study base will be critical to establishing the validity of study results.
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Effects of differential sampling frame coverage of controls by exposure in a case–control
study where the sampling frame for cases is assumed to have full case reporting. aIn this
study, under the assumption that opting out patterns are similar for cases and controls, we
illustrate the likely magnitude of γ/δ via the corresponding ratio of probabilities of a case
being on the drivers' license file used for controls. bTrue OR assuming no systematic or
random error.
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N = 2,988 SPRb,c (95% CI)
Age, y
    20–39   6.2 1 (reference)  
    40–69 93.8 1.12 (1.00–1.26)
Marital status at diagnosis
    Single, never married   5.4 1 (reference)  
    Married 77.6 0.90 (0.79–1.01)
    Living with partner   2.2 0.71 (0.55–0.91)
    Divorced, separated   9.1 0.83 (0.72–0.95)
    Widowed   4.7 0.89 (0.76–1.04)
Income
    <$50,000 49.2 1 (reference)  
    ≥$50,000 39.7 0.94 (0.89–1.00)
    Missing 11.1 0.89 (0.81–0.98)
Postmenopausal hormone use
    Never 66.0 1 (reference)  
    Ever 33.2 0.93 (0.88–0.98)
Ever use of antidepressant medication use
    No 68.3 1 (reference)  
    Yes 31.66 0.95 (0.93–0.98)
Race
    White, non-Hispanic 95.1 1 (reference)  
    Other   3.4 1.06 (0.94–1.20)
Education
    College degree or more 40.6 1 (reference)  
    Some college 26.3 1.01 (0.94–1.08)
    High school or less 33.1 1.02 (0.96–1.09)
Parity
    ≥3 36.5 1 (reference)  
    2 36.7 0.94 (0.89–1.00)
    1 11.7 0.86 (0.78–0.94)
    0 14.3 0.87 (0.80–0.96)
a
Not all categories sum to 100% due to missing values.
b
ORs and 95% CIs were derived by fitting a generalized linear model with the log link function.
c
Adjusted for parity, education, race, antidepressant medication use, hormone use, income, marital status at diagnosis, and age (over/under 40).
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